Literature DB >> 10214647

Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.

L A Curry1, D F Wagman.   

Abstract

Powerlifters have been suspected to be a population wherein use of anabolic androgenic steroids is prevalent (Yesalis, Herrick, & Buckley, 1988). To access commentary from these athletes on issues related to these drugs and the effectiveness of doping controls, a survey was developed. From 28 U.S. Powerlifting Team members who competed internationally since 1988, 26 were contacted by mail, and 15 questionnaires were returned. The questionnaire solicited yes/no responses and qualitative descriptions about current and previous use of anabolic androgenic steroids in powerlifting. Analysis indicated that ten U.S. Powerlifting Team members admitted to using these drugs, and five athletes admitted to beating the International Olympic Committee's doping control procedures. Reported use of anabolic androgenic steroids by these athletes was consistent with data presented by Yesalis, et al. and illustrated continued discrepancy between admitted use of these drugs prior to or during national and international events and the lack of reported positive test data. Discussion focused on the value of this study to elicit in an athlete's own words commentary specific to the use of anabolic androgenic steroids and the need for more effective doping controls.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214647     DOI: 10.2466/pms.1999.88.1.224

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  4 in total

Review 1.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

2.  Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.

Authors:  John Gleaves; Andrea Petróczi; Dirk Folkerts; Olivier de Hon; Emmanuel Macedo; Martial Saugy; Maarten Cruyff
Journal:  Sports Med       Date:  2021-04-26       Impact factor: 11.136

3.  Cardiac effects of anabolic steroids.

Authors:  J R Payne; P J Kotwinski; H E Montgomery
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

4.  Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.

Authors:  Nicole M Martin; Barham K Abu Dayyeh; Raymond T Chung
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.